MedPath

Investigation of Potential Retinal Toxicity Associated With Hair Dye Products Containing pPD Type Aromatic Amines

Not Applicable
Completed
Conditions
MEK Inhibitor-Associated Serous Retinopathy
Interventions
Device: OCT-B scan
Registration Number
NCT04222387
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

Hair dye products could induce minimal forms of MEKAR retinopathies (Mitogen-activated Extracellular signal-regulated Kinase - inhibitors associated retinopathies). These minimal forms of MEKAR are likely to be underdiagnosed, since the associated visual loss is usually mild and so this condition should be considered when patients report blurred vision. The aim of the study is to analyze whether in the current population that dyes the hair, minimal forms that go unnoticed by MEKAR retinopathies can be induced.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Hair dye up to one month before the inclusion
  • Hair dye product containing aromatic amines
Exclusion Criteria
  • Pregnant or lactating woman
  • Retinal pathology already known, or central serous choroiditis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Participants with hair dyeOCT-B scanHair dye product with pPD Type Aromatic Amines used up to 1 month before
Primary Outcome Measures
NameTimeMethod
% of patients with MEKAR retinopathy detected on OCT-B scanDay of inclusion, up to one month month after the last hair dye

Physiological parameter : Serous retinal detachment at the posterior pole, detected on OCT-B scan

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondation A de Rothschild

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath